Scientific Program

Conference Series LLC Ltd invites all the participants across the globe to attend 7th Annual congress on Probiotics, Nutrition and Microbes
Venue : Panorama Hotel Prague, Milevska 7, 140 63 Praha 4, Czech Republic.

Day 2 :

Probiotics 2018 International Conference Keynote Speaker Adel Penhasi photo
Biography:

Adel Penhasi, whose expertise spans the fi elds of polymer science and biomaterials, is currently Chief Science and Technology Offi cer of PolyCaps. Previously, he served as Vice President Innovative Research and Development at Dexcel Pharma where he managed the innovative research group for more than a decade. Adel Penhasi has published over 50 scientifi c papers, and he is the inventor of more than 55 patents and patent applications in different industrial applications such as drug delivery systems, medical devices and micro-encapsulations. He is a senior lecturer at The Azrieli College of Engineering Jerusalem - Pharmaceutical Engineering. He earned his PhD in Applied Chemistry form Hebrew University of Jerusalem

Abstract:

Powdered infant formula (PIF) is not a sterile product as the guidelines by the FAO/WHO point out. Th e presence of pathogenscan present a challenge to young infants, consequently while preparing PIF extra precautions need to be taken. PIF is currentlyprepared at room temperature and thus the activity of pathogenic bacteria is maintained. According to WHO guidelines, PIFshould be prepared at 70°C in order to destroy any contaminant which may exist in PIF. However, at this temperature, probiotic bacteria which may be contained in PIF may also be destroyed thus the advantages of probiotics will not be manifested.

PolyCaps has developed a unique microencapsulation technology which protects probiotic bacteria (PB) against hot water (70°C)during reconstitution of PIF in accordance with the new WHO guidelines. Harmful pathogens will of course be destroyed ordisactivated. Th e microcapsules are designed to dissolve immediately aft er cooling the liquid to feeding temperature releasing the alive PB. Additionally, the microencapsulation system ensures a low water activity (aw) and protects the PB which allows a high viability and an extended shelf life.

The microencapsulation system consists of an inner core containing PB and other ingredients, which is further surrounded by a unique 2-layer coating comprising at least one smart polymer. Th e latter forms a solid gel when heated, thereby preventing the transition of heat and water to the PB in the core. However, the solid gel layer dissolves aft er cooling to feeding temperature, allowing live PB to be released in the liquid.

Probiotics 2018 International Conference Keynote Speaker Marcelline T M Goyen photo
Biography:

Marcelline T M Goyen is an offi cial Dutch Skin Therapist with her own practice since 1999 and she has completed her Bachelor of Health Science since 2003. Her special interest in the cause of skin problems led her to investigate the relationship between skin and intestines, also called the Skin-Gut axis. She studied Gut therapy (2009) and started helping people with skin problems like eczema and acne by treating their gut dysbiose and changing diet and lifestyle. She is now fi nishing a book about the Skin- Gut axis in relation with the immune system and the microbiome. Her passion is to share knowledge about this axis and to trigger others to follow. She published many articles in several health magazines and is editor for NTVH (Dutch Journal for Skin Care).

Abstract:

Skin problems such as eczema and acne are still seen by most doctors as a chronic condition. Patients are told that they should learn to live with this. However, it is becoming increasingly clear that the human microbiome plays an important role in the cause and exacerbation of many disorders such as diabetes, ADHD, depression and intestinal disorders. In her practice, Marcelline discovered through extensive anamnesis on her patients with skin problems that intestinal and digestive problems seemed to go hand in hand with the skin complaints. Since then she guides skin patients in improving lifestyle and nutrition and in adjusting and improving the dysbiosis in the intestines. She uses feces examinations through a laboratory. A feces study of 19 acne patients (2011) that she set up showed surprising similarities that prompted many research questions. She also notices a relationship between dysbiosis in the gut and the role of parasites, including the B. hominis and D. fragilis, in the development of chronic skin problems such as eczema. She has achieved several special results in treating skin problems only from infl uencing the gut microbiota by diet, lifestyle change and pre- and probiotics. Th e diff erent factors for every individual skin patient such as food, allergy, in the past used medication including antibiotics, lifestyle and stress make treatment of skin patients still tailor-made. According to Marcelline, the treatment by infl uencing the gut microbiome off ers possibilities in the future to work from chronic skin diseases to healthy skin, without or thanks to the non-use of skin products or skin medication with all the potential for side
eff ects.